A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player. (1st July 2022)
- Record Type:
- Journal Article
- Title:
- A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player. (1st July 2022)
- Main Title:
- A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player
- Authors:
- Ezquer, Fernando
Quintanilla, María Elena
Morales, Paola
Santapau, Daniela
Munita, José Manuel
Moya-Flores, Francisco
Ezquer, Marcelo
Herrera-Marschitz, Mario
Israel, Yedy - Abstract:
- Abstract: Rationale: Gut microbiota communicates information to the brain. Some animals are born with a gut microbiota that predisposes to high alcohol consumption, and transplantation of fecal material from alcoholics to mice increases animal preference for ethanol. Alcohol-use-disorders are chronic conditions where relapse is the hallmark. A predictive animal model of relapse is the "alcohol deprivation effect" where ethanol re-access is allowed following chronic alcohol intake and a long alcohol deprivation. The present study evaluates the effect of gut microbiota modification on relapse, as an adjunct to N-acetylcysteine + Acetylsalicylic acid administration, which inhibits the alcohol-induced hyper-glutamatergic condition. Methods: Rats bred as heavy alcohol consumers (UChB) were allowed ethanol intake for one month, were deprived of alcohol for two-weeks and subsequently offered re-access to ethanol. Prior to ethanol re-access animals received orally either (i) vehicle-control, (ii) L actobacillus-rhamnosus -GG after antibiotic treatment (LGG); (iii) N-acetylcysteine+Acetylsalicylic acid (NAC/ASA) or (iv) both treatments: LGG+ (NAC/ASA). Results: Marked binge drinking (1.75 g ethanol/kg in 60 min) and blood alcohol levels exceeding 80 mg/dl were observed in the control group upon ethanol-re-access . Lactobacillus -GG or (NAC+ASA) treatments inhibited alcohol intake by 66–80%. The combination of both treatments virtually suppressed (inhibition of 90%) the re-accessAbstract: Rationale: Gut microbiota communicates information to the brain. Some animals are born with a gut microbiota that predisposes to high alcohol consumption, and transplantation of fecal material from alcoholics to mice increases animal preference for ethanol. Alcohol-use-disorders are chronic conditions where relapse is the hallmark. A predictive animal model of relapse is the "alcohol deprivation effect" where ethanol re-access is allowed following chronic alcohol intake and a long alcohol deprivation. The present study evaluates the effect of gut microbiota modification on relapse, as an adjunct to N-acetylcysteine + Acetylsalicylic acid administration, which inhibits the alcohol-induced hyper-glutamatergic condition. Methods: Rats bred as heavy alcohol consumers (UChB) were allowed ethanol intake for one month, were deprived of alcohol for two-weeks and subsequently offered re-access to ethanol. Prior to ethanol re-access animals received orally either (i) vehicle-control, (ii) L actobacillus-rhamnosus -GG after antibiotic treatment (LGG); (iii) N-acetylcysteine+Acetylsalicylic acid (NAC/ASA) or (iv) both treatments: LGG+ (NAC/ASA). Results: Marked binge drinking (1.75 g ethanol/kg in 60 min) and blood alcohol levels exceeding 80 mg/dl were observed in the control group upon ethanol-re-access . Lactobacillus -GG or (NAC+ASA) treatments inhibited alcohol intake by 66–80%. The combination of both treatments virtually suppressed (inhibition of 90%) the re-access binge-like drinking, showing additive effects. Treatment with NAC+ASA increased the levels of glutamate transporters xCT and GLT-1 in nucleus accumbens, while Lactobacillus-GG administration increased those of the dopamine transporter (DAT). Conclusions: The administration of a well-accepted probiotic may be of value as an adjunct in the treatment of alcohol-use-disorders. Graphical Abstract: Gut microbiota strongly influences ethanol relapse. Ethanol relapse intake following ethanol deprivation and re-access was significantly inhibited by the oral administration of Antibiotic/Lactobacillus. When combined with N- acetylcysteine + Acetylsalicylic acid ethanol relapse was 90% inhibited. ga1 … (more)
- Is Part Of:
- Drug and alcohol dependence. Volume 236(2022)
- Journal:
- Drug and alcohol dependence
- Issue:
- Volume 236(2022)
- Issue Display:
- Volume 236, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 236
- Issue:
- 2022
- Issue Sort Value:
- 2022-0236-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-07-01
- Subjects:
- ADE -- Alcohol relapse -- Gut microbiota -- Lactobacillus -- Treatment
Drug abuse -- Periodicals
Alcoholism -- Periodicals
616.86 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03768716 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.drugalcdep.2022.109466 ↗
- Languages:
- English
- ISSNs:
- 0376-8716
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3627.890000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21790.xml